<DOC>
	<DOCNO>NCT00768508</DOCNO>
	<brief_summary>This study would like test whether combination ondansetron naltrexone superior either medication alone placebo treatment alcohol dependence .</brief_summary>
	<brief_title>Combined Pharmacotherapies Alcoholism</brief_title>
	<detailed_description>We propose conduct 13 week randomize , control clinical trial evaluate safety efficacy ondansetron naltrexone alone combination.Eligible subject randomize placebo , ondansetron , naltrexone , ondansetron + naltrexone treatment . All subject receive weekly CBT ( Cognitive Behavioral Therapy ) session .</detailed_description>
	<mesh_term>Alcoholism</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Males female give write informed consent . Ages 18 year must weigh least 40 kg 140 kg . Good physical health determine complete physical examination , EKG within normal limit , laboratory screening test within acceptable parameter ( see exclusion criterion ) . Current DSMIV diagnosis alcohol dependence AUDIT score equal 8 . Currently drink Provide evidence stable residence last month prior enrollment study , plan move next three month . The pregnancy test female intake must negative . Additionally , woman childbearing potential must use acceptable form contraception . These include : oral contraceptive , hormonal ( levonorgestrel ) surgical implant , barrier plus spermicide . Literate English able read , understand , complete rating scale questionnaire accurately , follow instruction , make use behavioral treatment . Answer advertisement newspaper/radio/television , refer health care professional express wish stop drinking . Willingness participate behavioral treatment alcoholism . Any current axis I DSM IV psychiatric disorder alcohol nicotine dependence Elevation liver enzyme ( SGOT ) , serum glutamic pyruvic transaminase ( SGPT ) , blood urea nitrogen ( BUN ) , lactate dehydrogenase ( LDH ) great four time normal range , clinically significant elevate direct bilirubin deem principal investigator . Severe alcohol withdrawal symptom physicians opinion require inpatient treatment . Serious medical comorbidity require medical intervention close supervision , condition interfere receipt ondansetron . Severe lifethreatening adverse reaction medication past clinical trial . Female patient pregnant , lactating , adhere acceptable form contraception time study . Received inpatient outpatient treatment alcohol dependence within last 30 day ( support group AA exclusionary ) . Compelled participate alcohol treatment program maintain liberty . Members household . Concurrent treatment medication potential effect alcohol consumption relate behavior , mood . These include : opiate antagonist ( e.g . naltrexone ) , glutamate antagonist ( e.g. , acamprosate ) , serotonin reuptake inhibitor ( e.g . fluoxetine ) , serotonin antagonist ( e.g . ritanserin buspirone ) , antidepressant ( e.g . tricylic antidepressant monoamine oxidase inhibitor ) , dopamine antagonist ( e.g . haloperidol ) , calcium channel antagonist ( e.g . isradipine ) , compound action similar disulfiram ( antabuse ) nicotine . Before doubleblind randomization , urine must free opiate , cocaine , amphetamine , barbiturate , benzodiazepine , prescription nonprescription drug . Pyrexia unknown origin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Alcohol</keyword>
	<keyword>Alcohol Dependence</keyword>
	<keyword>Alcoholism</keyword>
</DOC>